Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children [Phase 3]

View source ↗

Summary

This document updates on a Phase 3 clinical trial evaluating CAR-T cell therapy for refractory or recurrent lupus nephritis in children, which is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAR-T cell therapy

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Lupus Nephritis | Phase 3 | Status: RECRUITING